Having trouble accessing articles? Reset your cache.

Nov. 4 Company Quick Takes: FDA approves RedHill’s antibiotic; plus NiKang, Revolution-Amgen, Aveo and Tmunity-Oncora

RedHill gets FDA approval for antibiotic
FDA approved Talicia from RedHill Biopharma Ltd. (Tel Aviv:RDHL; NASDAQ:RDHL) to treat Helicobacter pylori infection in adults. RedHill plans to launch the fixed-dose combination of

Read the full word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE